Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
21 GBX | +25.00% |
|
+302.29% | +46.67% |
08:00am | Crism Therapeutics Affirms Plan to File Clinical Trial Application for Lead Product in H2 | MT |
07-03 | Crism flags contract talks, reacts to share price surge | AN |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CRISM THERAPEUTICS CORPORATION | Other Pharmaceuticals | +25.00% | +302.29% | +46.67% | -34.00% | -93.86% | 1.87M | - | - | - |
- Stock Market
- Equities
- CRTX Stock
- Charts CRISM Therapeutics Corporation
- Relative Strength Chart